Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients.

Koji Tanaka; Nanae Harashima; Fumihiko Niiya; Yoshiaki Miyagi; Naoya Hida; Mika Ochi; Nobue Imai; Mamoru Harada; Kyogo Itoh; Shigeki Shichijo

doi:10.1111/j.1349-7006.2002.tb01259.x

Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients.

Identifier:nobleid.org/w1/20260515/BCAF20CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BCAF20CD.svg?ark=w1%2F20260515%2FBCAF20CD)](https://nobleid.org/work/w1/20260515/BCAF20CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients.

Identifier:nobleid.org/w1/20260515/BCAF20CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BCAF20CD.svg?ark=w1%2F20260515%2FBCAF20CD)](https://nobleid.org/work/w1/20260515/BCAF20CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work